Introducing the

Multi-Cancer Early Detection Test

Multi-Cancer Early Detection Test

Cancer is most treatable when detected early. Our multi-cancer early detection test is a non-invasive blood test designed to detect biomarkers associated with several cancer types — even before symptoms appear.

What is Multi-Cancer Early Detection Test

Multi-Cancer Early Detection Test (MCED) is a simple blood test that can detect up to 113 types of cancer. Unlike the traditional cancer tests, our MCED test analyzes circulating biomarkers in the blood to detect subtle signals associated with over 50+ common cancers. This includes hard-to-screen cancers with no routine tests available, giving you and your healthcare provider unprecedented insight into your cancer risk long before it becomes symptomatic.

All It Takes is One Blood Test

Test Up to 113 Types of Cancer

This test can detect signals associated with many cancer types, including Lung, Colorectal, Liver, Breast, Uterine, Ovarian, Cervical, Thyroid, Blood, Gastric, Skin, Pancreatic, Prostate, Bladder, Kidney, Head and Neck and Brain cancers.

Breast Cancers

Basal (Triple-Negative) Carcinomas
Ductal Carcinomas
ER-Positive & PR-Positive Carcinomas
HER-Positive Carcinomas
Lobular Carcinomas
Luminal Carcinomas
Carcinomas
Metastatic Breast Cancers
Invasive lobular carcinoma
Paget’s disease of the breast
Male breast cancer
Papillary carcinoma

23. Adenocarcinomas

24. Adenomas

25. Gastrointestinal Stromal Tumors (GIST)Liver Cancers

Lung Cancers

13. Adenocarcinomas

14. Malignant Pleural Mesotheliomas

15. Non-Small Cell Lung Cancers (NSCLC)

16. Squamous Cell Carcinomas

17. Large Cell Carcinomas

18. Small Cell Lung Cancers (SCLC)

19. Adenocarcinomas

Colorectal Cancers

Prostate Cancers

20. Adenocarcinomas

21. Advanced Prostate Cancers

22. Ductal Carcinomas

Liver Cancers

26. Cholangiocarcinomas

27. Hepatoblastomas

28. Hepatocellular Carcinomas

Thyroid Cancers

29. Adenoma-Nodule-Goitre

30. Anaplastic Carcinomas

31. Papillary Carcinomas

Kidney Cancers

32. Clear Cell Renal Cell Carcinoma

33. Wilms Tumor

34. Squamous cell carcinoma

35. Cervical adenocarcinomas

Cervical Cancers

Head and Neck Cancer

36. Nasopharyngeal Cancer

37. Oropharyngeal Cancer

38. Laryngeal Cancer

39. Salivary Cancer

40. Oral Cancer

41. Oesophagal Cancer

Bladder Cancer

42. Adenocarcinomas

43. Transitional Cell Carcinomas

44. Urothelial carcinoma

Pancreatic Cancer

45. Ductal Adenocarcinomas

46. Ductal Carcinomas

Ovarian Cancer

47. Germ cell tumors

48. Ovarian stromal tumors

49. Endometrioid

50. Epithelial ovarian tumors

51. Mucinous carcinoma

52. Clear-cell adenocarcinoma

53. Serous carcinoma

54. Carcinosarcoma

Melanomas

55. Cutaneous Melanomas

56. Malignant Melanomas

57. Mucosal Melanomas

58. Ocular Melanomas

59. Uveal Melanomas

Leukemia

60. Acute Lymphoblastic Leukemia (ALL)

61. Acute Myeloid Leukemia (AML)

62. Acute Promyelocytic Leukemia (APML; APL)

63. Atypical Chronic Myeloid Leukemia (aCML)

64. Chronic Lymphocytic Leukemia (CLL)

65. Chronic Myeloid Leukemia (CML)

66. Chronic Myelomonocytic Leukemia (CMML)

67. Hairy Cell Leukemia

68. Juvenile Myelomonocytic Leukemia

69. Chronic Neutrophilic Leukemia

Myeloid Neoplasms

70. Myelodysplastic Syndromes (MDS)

71. Myeloproliferative Neoplasms (MPN)

72. Multiple Myeloma

73. Plasma Cell Myeloma

74. Polycythemia Vera

75. Primary Myelofibrosis

76. Systemic Mastocytosis

Endometrial Carcinoma

77. Epithelial Carcinomas

78. Granulosa Cell Tumors

79. Mixed Adenosquamous Carcinomas

80. Mucinous Carcinomas

81. Serous Carcinomas

Lymphomas

82. Anaplastic Large Cell Lymphomas

83. B Cell Lymphomas

84. Burkitt Lymphomas

85. Diffuse Large B Cell Lymphomas

86. Follicular Lymphomas

87. Hodgkin lymphoma

88. Lymphocytic Lymphomas

89. Mantle Cell Lymphomas

90. Marginal Zone Lymphomas

91. Mucosa-Associated Lymphoid Tissue(MALT) Lymphomas

92. Non-Hodgkin Lymphomas

93. Primary Cutaneous Lymphomas

94. Small Lymphocytic Lymphomas

95. T Cell Lymphomas

Brain Cancers

96. Anaplastic Glial Tumors

97. Astrocytomas

98. Ependymomas

99. Glioblastomas

100. Gliomas

101. Medulloblastomas

102. Meningiomas

103. Oligodendrogliomas

Sarcoma

104. Askins Tumors

105. Biphenotypic Sarcomas with Myogenic & Neural Differentiation

106. Clear Cell Sarcomas

107. Congenital (Infantile) Fibrosarcomas

108. Desmoplastic Small Round Cell Tumors

109. Ewing’s Sarcomas

110. Fibrosarcomas

111. Myofibroblastic Sarcomas

112. Rhabdomyosarcomas

113. Small Round Cell Tumors

Who is This Test For?

This Non-Invasive test is recommended for individuals aged 40 and above, individuals with higher cancer risks due to family history and lifestyle factors, women who are not pregnant and those who have been free from cancer for at least 3 years.

Individuals with family history

Individuals who smoke, drink alcohol regularly, adopt unhealthy eating habits & live a sedentary lifestyle

Individuals aged 40 & above

Why Choose Us?

Comprehensive

Identifies over 110 types of cancer, providing an extensive screening capability that surpasses traditional methods.

Accurate

When a cancer signal is detected, the test accurately predicts its origin, expediting intervention.

Non-Invasive

Single blood draw , simplifies the screening process, making it more accessible and less invasive for patients.

Fast & Reliable

All tests are conducted locally in our ISO 15189 certified lab, with results delivered within 7-14 working days from sample receipt.

Understanding Test Results

Negative (-)

This means that no cancer signal was found; however, not all cancers can be detected by the test. Be sure to continue with routine recommended cancer screening tests.

If the test result is positive, the report will also indicate the most likely source of the cancer signal. However, it is important to note that these results must be verified through additional diagnostic tests as per standard medical procedure. The results should also be considered in relation to the individual's specific health risks. Even if a cancer signal is identified and the origin is not confirmed by diagnostic tests, there is still a heightened chance of cancer and further examination may be necessary.

Keep in mind that this test is only a component of your overall health screening and treatment plan. Always discuss your options and what the results mean with your healthcare provider.

Get Tested Now